Chargement en cours...

Biomarker development for myasthenia gravis

Biomarkers are defined as characteristics (proteins, RNA, single nucleotide polymorphisms, imaging) that are objectively measured and evaluated as an indicator of pathogenic processes or pharmacologic responses to a therapeutic intervention. Biomarkers are important in clinical trials where the robu...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kaminski, Henry J., Kusner, Linda L., Wolfe, Gil I., Aban, Inmaculada, Minisman, Greg, Conwit, Robin, Cutter, Gary
Format: Artigo
Langue:Inglês
Publié: 2012
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3539232/
https://ncbi.nlm.nih.gov/pubmed/23278584
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1749-6632.2012.06787.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!